New technology, jointly created by Case Western Reserve University and University Hospitals Cleveland Medical Center, offers a promising potential solution to ...
Case Western Reserve University and Boston-based Akouos have entered into an exclusive licensing agreement to develop a patented gene therapy with the potentia...
CWRU spinout Convelo partners with San Francisco company to develop medicines for neurological disorders
Crain’s Cleveland Business: A company founded by an...
Convelo Therapeutics Inc., a Cleveland company based on the research findings of Paul Tesar and Drew Adams at the Case Western Reserve University School of Med...
NervGen Pharma Corp., a Vancouver-based company founded to develop regenerative-medicine technology licensed from Case Western Reserve University, raised about...
Only Ohio institution to receive funding all three years
The Ohio Third Frontier Commission has awarded Case Western Reserve University its third $500,000 gran...
Case Western Reserve University and Engine Biosciences Pte Ltd have signed an exclusive license option in which the drug discovery company will evaluate univers...
I-Corps@Ohio, an initiative from the Ohio Department of Higher Education, has expanded Case Western Reserve University, as well as Cleveland Clinic and Wright S...
Case Western Reserve University and NervGen Pharma Corp., based in Vancouver, have entered into an exclusive licensing agreement to research, develop and commer...
Technology developed by Case Western Reserve researchers; licensed by Technology Transfer Office
XaTek Inc., a Cleveland-based company developing a portable se...
